Is Aminosyn 4.25% W/ Dextrose 25% In Plastic Container still available?

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container (NDA 019119) is listed as Discontinued in the FDA Orange Book — it is no longer marketed. A discontinued status is not, by itself, a determination that the drug was withdrawn for safety or effectiveness.

Does Aminosyn 4.25% W/ Dextrose 25% In Plastic Container have a generic?

The FDA Orange Book does not currently list an approved generic (ANDA) sharing Aminosyn 4.25% W/ Dextrose 25% In Plastic Container's active ingredient (Amino Acids; Dextrose).

What is Aminosyn 4.25% W/ Dextrose 25% In Plastic Container's FDA application number?

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container is approved under NDA 019119, held by Abbott.

Orange Book product · Brand (NDA)

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container

Amino Acids; Dextrose

Brand (NDA)NDA 019119Discontinued Abbott

Approved

Oct 11, 1984

Application

Brand (NDA)

TE code

Not listed

Listed patents

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container (Amino Acids; Dextrose) is Abbott's brand-name drug, approved by the FDA under NDA 019119 in 1984. Its marketing status is listed as discontinued; a discontinued listing is not, by itself, a finding that the drug was withdrawn for safety or effectiveness.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Approval
FDA approval date of this drug product.
Oct 11, 1984
42 yr 4 mo ago
Today

FDA product record

Pharmaceutical detail

Active ingredient

AMINO ACIDS; DEXTROSE

Strength

4.25%;25GM/100ML

Dosage form

INJECTABLE

Route

INJECTION

TE code

Not listed

Application

NDA 019119

Product number

001

Marketing status

Discontinued

Reference listed drug (RLD)

Reference standard (RS)

Brand + generics

Active-ingredient family

This is a brand (NDA) product. Other products sharing this active ingredient are listed below.

View full Amino Acids; Dextrose family

Orange Book patent file

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Aminosyn 4.25% W/ Dextrose 25% In Plastic Container — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Amino Acids; Dextrose active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo